Centre Hospitalier Intercommunal de Créteil
Créteil, Val De Marne, 94000, France
NCT Number: NCT07143526
The goal of this observational study is to compare swept source optical coherence tomography devices ability to detect macular neovascularisation when there is a large pigment epithelium detachment higher than 250 microns
Trial opening soon.
Get NotifiedAll sexes
Observational
Créteil, Val De Marne, 94000, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Two Optical Coherence Tomography Angiography swept source devices are compared for the detection of large pigment epithelium detachments in age related macular degeneration. The sensitivity of the devices is compared in both the automatic segmentation done by the device and the manual segmentation done by a retina specialist.
Time frame: Day 1
The optical coherence tomography angiography devices are known to have a difficult time detecting neovascularisation in the cases of large pigment epithelium detachments (PED), because of the many layers and the distance the OCT signal has to cross. The automatic retina segmentation (done by the device of the different retina layers plays a big role in this detection. It's also disturbed by the height of the PED.
This study aims to compare the sensitivity of two swept source OCT devices available in the market : Bmizar, Towardpi and Plexelite, Zeiss.
After the exam image acquisition, a retina specialist will try to make a manual segmentation of the retina analysed to help the detection of macular neovascularisation that would have been missed in the "normal" automatic segmentation done by the device.
Contact information is provided by the study sponsor or research team.
University of Trieste
Other
Comparison of Two Swept-source Optical Coherence Tomography Angiography (OCTA) Devices (Bmizar and Plexelite) for Detecting Macular Neovascularisation With Large (More Than 250 Microns) Pigment Epithelium Detachment (PED) in Age Related Macular Degeneration
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07554690
AMD - Age-Related Macular Degeneration, Eye Diseases
Roma, Italy
View Trial DetailsNCT07418177
AMD - Age-Related Macular Degeneration, Eye Diseases
Nanjing, Jiangsu, China
View Trial DetailsNCT07409389
AMD - Age-Related Macular Degeneration, Eye Diseases
Hong Kong, China
View Trial DetailsNCT07060196
AMD - Age-Related Macular Degeneration, Eye Diseases
Alexandroupoli, Greece
View Trial Details